"While the $16 EPS floor was lower than expected, it does give investors/analysts a base to model off of, and potentially sets up UNH to return to the 'beat and raise' cadence that its investors had become accustomed to," said James Harlow, senior vice president at Novare Capital Management.

The beleaguered company plans to focus on business fundamentals, cut Medicare Advantage plans, raise prices and forge a new relationship with regulators as it slogs its way back to favored status with Wall Street.

Investors will be looking for a path to a turnaround from UnitedHealth’s earnings release, after an abrupt CEO change and over 40% drop in the company’s stock.

UnitedHealth faces regulatory scrutiny, fraud allegations, and leadership turmoil. Click here to learn why UNH stock is a Hold.

UnitedHealth shares tumbled Thursday after the health insurance giant confirmed that it’s the subject of a Department of Justice investigation. Monitor these key chart levels.